These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34923038)

  • 1. Targeting Endocannabinoid System in Epilepsy: For Good or for Bad.
    Martínez-Aguirre C; Cinar R; Rocha L
    Neuroscience; 2022 Feb; 482():172-185. PubMed ID: 34923038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
    Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
    Ruhl T; Karthaus N; Kim BS; Beier JP
    Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids.
    Cheung KAK; Peiris H; Wallace G; Holland OJ; Mitchell MD
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanism and Cannabinoid Pharmacology.
    Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
    Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Introduction to the Endogenous Cannabinoid System.
    Lu HC; Mackie K
    Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
    De Petrocellis L; Di Marzo V
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.
    Darmani NA
    Methods Mol Med; 2006; 123():169-89. PubMed ID: 16506408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar disorder and the endocannabinoid system.
    Arjmand S; Behzadi M; Kohlmeier KA; Mazhari S; Sabahi A; Shabani M
    Acta Neuropsychiatr; 2019 Aug; 31(4):193-201. PubMed ID: 31159897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
    Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
    J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.
    Zogopoulos P; Vasileiou I; Patsouris E; Theocharis S
    J Appl Toxicol; 2013 Apr; 33(4):246-64. PubMed ID: 23296873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cannabinoids in the development of fatty liver (steatosis).
    Purohit V; Rapaka R; Shurtleff D
    AAPS J; 2010 Jun; 12(2):233-7. PubMed ID: 20204561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids in depressive disorders.
    Poleszak E; Wośko S; Sławińska K; Szopa A; Wróbel A; Serefko A
    Life Sci; 2018 Nov; 213():18-24. PubMed ID: 30290188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
    Charytoniuk T; Zywno H; Konstantynowicz-Nowicka K; Berk K; Bzdega W; Chabowski A
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
    Han QW; Yuan YH; Chen NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals.
    Vlachou S; Panagis G
    Curr Pharm Des; 2014; 20(13):2072-88. PubMed ID: 23829366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CB
    Ji X; Zeng Y; Wu J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Hum Reprod Update; 2020 Jun; 26(4):586-602. PubMed ID: 32347309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
    Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
    Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.